Arrhythmia Disorders News

A system including a leadless pacemaker and a subcutaneous implantable cardioverter defibrillator that wirelessly communicate with each other was safe in patients at risk for fatal ventricular arrhythmias at 6 months, researchers reported.

For athletes with arrhythmias, the return-to-play decision should be individualized based on appropriate risk assessment and treatment and the shared decision-making process should be used, according to a new expert statement.

In patients with atrial fibrillation who had ablation, those assigned a Mediterranean diet enriched with extra-virgin olive oil were less likely to have arrhythmia recurrence than those with no dietary restrictions, researchers reported.

No athlete with a positive test for genetic heart disease but a negligible clinical phenotype had a genetic heart disease-associated death or cardiac event in more than 1,500 person-years of follow-up, researchers reported.

In patients with type 2 diabetes who underwent ablation for atrial fibrillation, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes, researchers reported at Heart Rhythm 2024.

A new guideline on hypertrophic cardiomyopathy endorses the use of cardiac myosin inhibitors for certain patients with obstructive HCM and encourages exercise in all patients with HCM.

Patients with systemic sclerosis who demonstrate left ventricular abnormalities, either overt or “subclinical,” have poorer survival and increased shortness of breath, according to data published in Seminars in Arthritis and Rheumatism.

In a large Danish cohort, heart failure was a more significant CV complication than stroke after diagnosis of atrial fibrillation, which became more common over 20 years.

Arrhythmia disorders in patients with adult congenital heart disease may significantly contribute to hospitalization and mortality risk, according to data published in the Journal of the American Heart Association.

ATLANTA — A screening study presented at the American College of Cardiology Scientific Session showed that there is a high prevalence of unrecognized heart disease among former National Football League players.